FIELD: medicine.
SUBSTANCE: present invention relates to immunology. Disclosed is a chimeric antigenic receptor (CAR), which contains a disiahoganglioside (GD2)-binding domain. Also disclosed is a nucleic acid encoding a CAR of the invention; an expression vector; T-cells and a method for producing T-cells. There are also described a pharmaceutical composition, a method of treating a malignant tumour and use of T-cell in preparing a drug for treating a malignant tumour. Disclosed CAR provides increased production of INF-γ, proliferation of CAR-T-cells and destruction of neuroblastoma cells in comparison with CAR on the basis of antibody 14g2a.
EFFECT: this invention may find further application in therapy.
26 cl, 15 dwg, 10 ex
Title | Year | Author | Number |
---|---|---|---|
CHIMERIC ANTIGEN RECEPTOR | 2014 |
|
RU2684713C2 |
CELL | 2016 |
|
RU2729158C2 |
CELL | 2014 |
|
RU2732236C2 |
CELL | 2014 |
|
RU2717984C2 |
SIGNAL SYSTEM | 2015 |
|
RU2731638C2 |
CHIMERIC ANTIGEN RECEPTORS TO MYELOMA KAPPA ANTIGEN AND VERSIONS OF THEIR APPLICATION | 2016 |
|
RU2743188C2 |
CELL | 2015 |
|
RU2768019C2 |
CHIMERIC ANTIGEN RECEPTOR | 2016 |
|
RU2752880C2 |
CHIMERIC ANTIGEN RECEPTORS AND THEIR PRODUCTION METHODS | 2015 |
|
RU2753965C2 |
CHIMERIC CYTOKINE RECEPTOR | 2016 |
|
RU2826122C1 |
Authors
Dates
2019-04-18—Published
2015-03-06—Filed